Patents by Inventor Tuula Heinonen

Tuula Heinonen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cell culture plate, method for preparing thereof and method for detecting a substance
    Publication number: 20200385660
    Abstract: A cell culture plate includes one or more cell culture well(s) including at least one barrier for dividing the well into at least two compartments, wherein the barrier includes nanofibrillar cellulose hydrogel, and a method for the preparation thereof. A method for detecting a substance is also disclosed.
    Type: Application
    Filed: May 19, 2020
    Publication date: December 10, 2020
    Inventors: Markus NUOPPONEN, Lauri PAASONEN, Marika MANNERSTRÖM, Tuula HEINONEN, Tarja TOIMELA
  • IN VITRO CARDIOVASCULAR MODEL
    Publication number: 20140206029
    Abstract: The present invention relates to a tubule forming platform and an in vitro cardiovascular model for use in pharmacological studies. Furthermore, the invention relates to methods for the preparation said platform and model, and to a method of determining a biological activity of a test substance in said platform and cardiovascular model. Still further, the invention relates to an implantable cardiac structure for use in the treatment of cardiac disorders.
    Type: Application
    Filed: June 14, 2012
    Publication date: July 24, 2014
    Applicant: TAMPEREEN YLIOPISTO
    Inventors: Katriina Aalto-Setälä, Tuula Heinonen, Erja Kerkelä, Jertta-Riina Sarkanen, Hanna Vuorenpää, Timo Ylikomi
  • Reference compound for use in the analysis of levosimendan batches
    Patent number: 6340764
    Abstract: A pyridazinyl derivative (I) and its use as a reference compound in the determination of potentially genotoxic impurities in levosimendan samples. An analytic method for the determination of potentially genotoxic impurities in levosimendan samples wherein (I) is used as a reference compound. Levosimendan is a medicament useful in the treatment of heart failure.
    Type: Grant
    Filed: February 20, 2001
    Date of Patent: January 22, 2002
    Assignee: Orion Corporation
    Inventors: Reijo Bäckström, Tuula Heinonen, Tuula Hauta-Aho